Considerations Towards Development of In Vivo Gene Therapies – a Risk Based Approach

Time: 8:15 am
day: Day Two

Details:

  • In vivo Gene Therapy: key principles and major cmc challenges
  • Understanding the linkage between CMC and clinical outcomes

Speakers: